Overview

Comparison of the Efficacy and Safety of Tiropramide and Octylonium in the Treatment of Irritable Bowel Syndrome

Status:
Unknown status
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to compare the Efficacy and Safety of Tiropramide HCl and Octylonium bromide in the Treatment of Irritable Bowel Syndrome.
Phase:
Phase 4
Details
Lead Sponsor:
Daewoong Pharmaceutical Co. LTD.
Treatments:
Bromides
Octylonium
Tiropramide